Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Endogenous Endophthalmitis in the Inpatient Setting

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Theodore Leng, Stanford University
ClinicalTrials.gov Identifier:
NCT01323868
First received: March 24, 2011
Last updated: November 17, 2014
Last verified: November 2014

March 24, 2011
November 17, 2014
July 2010
June 2013   (final data collection date for primary outcome measure)
Positive intraocular infection [ Time Frame: 1 day ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01323868 on ClinicalTrials.gov Archive Site
Visual acuity [ Time Frame: 2 wk ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Endogenous Endophthalmitis in the Inpatient Setting
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes

The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.

Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).

Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Inpatients at Stanford Hospital with positive blood cultures who receive an Ophthalmology consultation and eye examination.

Endophthalmitis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
145
June 2013
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:All patients admitted to Stanford Hospital that have a systemic blood-borne infection and on which an Ophthalmology consult to rule out endogenous endophthalmitis is performed will be included in the study.

Exclusion Criteria:None

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01323868
SU-03232011-7621, IRB-18785
Not Provided
Theodore Leng, Stanford University
Stanford University
Not Provided
Principal Investigator: Theodore Leng Stanford University
Stanford University
November 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP